Does EZETIMIBE Cause Product dose omission issue? 64 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Product dose omission issue have been filed in association with EZETIMIBE (Ezetimibe). This represents 0.5% of all adverse event reports for EZETIMIBE.
64
Reports of Product dose omission issue with EZETIMIBE
0.5%
of all EZETIMIBE reports
0
Deaths
13
Hospitalizations
How Dangerous Is Product dose omission issue From EZETIMIBE?
Of the 64 reports, 13 (20.3%) required hospitalization, and 1 (1.6%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE. However, 64 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE Cause?
Myalgia (2,066)
Fatigue (876)
Drug ineffective (812)
Arthralgia (766)
Dyspnoea (766)
Nausea (742)
Dizziness (717)
Diarrhoea (688)
Headache (626)
Malaise (591)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which EZETIMIBE Alternatives Have Lower Product dose omission issue Risk?
EZETIMIBE vs EZETIMIBE\ROSUVASTATIN
EZETIMIBE vs EZETIMIBE\SIMVASTATIN
EZETIMIBE vs EZOGABINE
EZETIMIBE vs FACTOR XIII CONCENTRATE
EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI